Bioptik Technology Incorporation (TPEX:4161)
Taiwan · Delayed Price · Currency is TWD 22.85
-0.05 (-0.22%)
May 29, 2026, 1:30 PM CST
TPEX:4161 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 865.76 | 837.19 | 865.34 | 828.5 | 767.75 | 737.89 | |
Revenue Growth (YoY) | 2.92% | -3.25% | 4.45% | 7.91% | 4.05% | 51.95% |
Cost of Revenue | 620.67 | 593.68 | 597.43 | 588.96 | 590.29 | 574.35 |
Gross Profit | 245.09 | 243.51 | 267.91 | 239.54 | 177.46 | 163.55 |
Selling, General & Admin | 103.37 | 101.77 | 102.56 | 77.83 | 79.9 | 79.17 |
Research & Development | 75.41 | 75.2 | 75.35 | 71.47 | 58.3 | 48.94 |
Operating Expenses | 178.7 | 176.78 | 178.07 | 149.59 | 137.99 | 127.82 |
Operating Income | 66.39 | 66.73 | 89.84 | 89.95 | 39.48 | 35.73 |
Interest Expense | -7.81 | -7.61 | -9.13 | -11 | -9.19 | -7.82 |
Interest & Investment Income | 4.11 | 4.57 | 8.99 | 10.7 | 4.01 | 1.36 |
Currency Exchange Gain (Loss) | -0.67 | -0.67 | 13.32 | 4.95 | 29.94 | -9.45 |
Other Non Operating Income (Expenses) | 8.16 | 3.83 | 3.57 | 3.14 | 4.62 | 5.52 |
EBT Excluding Unusual Items | 70.17 | 66.85 | 106.58 | 97.75 | 68.86 | 25.34 |
Gain (Loss) on Sale of Investments | 17.25 | 17.25 | 4.63 | 8.69 | -6.14 | -5.72 |
Gain (Loss) on Sale of Assets | 1.22 | 1.22 | -0.9 | 0.02 | 0.06 | 0 |
Other Unusual Items | - | - | - | 0.02 | 0.03 | - |
Pretax Income | 88.64 | 85.32 | 110.32 | 106.47 | 62.81 | 19.62 |
Income Tax Expense | 16.18 | 15.48 | 17.98 | 21.89 | 15.78 | -0.94 |
Earnings From Continuing Operations | 72.47 | 69.84 | 92.34 | 84.58 | 47.03 | 20.56 |
Minority Interest in Earnings | 1.48 | 1.35 | 1.23 | 1.13 | 1.47 | 2.04 |
Net Income | 73.94 | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 |
Net Income to Common | 73.94 | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 |
Net Income Growth | -18.10% | -23.92% | 9.17% | 76.73% | 114.67% | - |
Shares Outstanding (Basic) | 60 | 58 | 58 | 58 | 57 | 57 |
Shares Outstanding (Diluted) | 60 | 59 | 59 | 58 | 58 | 57 |
Shares Change (YoY) | 1.76% | -0.13% | 1.41% | 0.77% | 0.33% | 0.15% |
EPS (Basic) | 1.24 | 1.23 | 1.62 | 1.49 | 0.85 | 0.39 |
EPS (Diluted) | 1.23 | 1.21 | 1.59 | 1.48 | 0.84 | 0.39 |
EPS Growth | -19.35% | -23.90% | 7.59% | 75.34% | 113.67% | - |
Free Cash Flow | -11.52 | 40.82 | 143.9 | 175.53 | 38.13 | -60.29 |
Free Cash Flow Per Share | -0.19 | 0.69 | 2.45 | 3.03 | 0.66 | -1.05 |
Dividend Per Share | - | 0.700 | 0.300 | 0.619 | - | 0.253 |
Dividend Growth | - | 133.33% | -51.57% | - | - | - |
Gross Margin | 28.31% | 29.09% | 30.96% | 28.91% | 23.11% | 22.16% |
Operating Margin | 7.67% | 7.97% | 10.38% | 10.86% | 5.14% | 4.84% |
Profit Margin | 8.54% | 8.50% | 10.81% | 10.35% | 6.32% | 3.06% |
Free Cash Flow Margin | -1.33% | 4.88% | 16.63% | 21.19% | 4.97% | -8.17% |
EBITDA | 93.59 | 94.11 | 120.11 | 119.73 | 67.73 | 67.29 |
EBITDA Margin | 10.81% | 11.24% | 13.88% | 14.45% | 8.82% | 9.12% |
D&A For EBITDA | 27.2 | 27.37 | 30.27 | 29.78 | 28.25 | 31.57 |
EBIT | 66.39 | 66.73 | 89.84 | 89.95 | 39.48 | 35.73 |
EBIT Margin | 7.67% | 7.97% | 10.38% | 10.86% | 5.14% | 4.84% |
Effective Tax Rate | 18.25% | 18.14% | 16.30% | 20.56% | 25.12% | - |